Compare Stocks
Compare up to four stocks to (UTHR) by adding the symbol or company name.
UTHR
Compare up to three stocks to UTHR by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value 11.82B | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV 9.62B | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings 12.51 | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM 21.12 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
Industry | Industry Biotechnology | Industry -- | Industry -- | Industry -- |
CEO | CEO Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. | CEO -- | CEO -- | CEO -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week 1.50% | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months 23.16% | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD 21.12% | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year 24.45% | 1 Year -- | 1 Year -- | 1 Year -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue 2.50B | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses 963.40M | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income 1.26B | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y 33.70% | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit 2.22B | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory 120.20M | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover 11.31 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops 979.70M | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx -227.30M | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI 236.80M | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow 752.40M | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E 12.51 | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E 11.26 | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF 17.47 | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV 2.20 | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S 5.26 | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA 6.48 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin 50.31% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin 88.87% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin 42.05% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS 22.36 | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth 26.95% | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets 16.36% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital 15.54% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of May 13, 2024 | UTHR United Therapeutics Corporation | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % 105.76% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |